SAN FRANCISCO--(BW HealthWire)--Dec. 24, 1997--A bacterial infection that afflicted tens of thousands of soldiers in the trenches during the first World War is making a comeback of sorts, threatening the lives of homeless AIDS patients. The discovery was made by a research team led by Jane Koehler, MD, a microbiologist
LOS ANGELES--(BUSINESS WIRE)--Dec. 23, 1997--The state of California has agreed to pay $800,000 to settle a lawsuit brought by AIDS Healthcare Foundation (AHF) for managed care services it provided, and to make additional future payments totaling $1.45 million. This settlement guarantees the viability of our innovative
VANCOUVER, Wash.--(BUSINESS WIRE)--Dec. 11, 1997--Saliva Diagnostic Systems, Inc. (Nasdaq: SALV - news, SALVW - news) demonstrated its latest rapid test, StatSimple(TM) pylori, in Europe at the recent Medica trade show in Dusseldorf, Germany . StatSimple pylori is a self-contained system for the collection, processing
SAN FRANCISCO--(BW HealthWire)--Dec. 10, 1997--People who are experiencing severe burning foot pain associated with HIV may participate in a UCSF clinical trial that is evaluating a treatment derived from chili peppers. The study, conducted by Wendye Robbins, M.D., UCSF assistant clinical professor of anesthesiology, i
SAN DIEGO--(BW HealthWire)--Dec. 10, 1997--NeXstar Pharmaceuticals Inc. (NASDAQ: NXTR) announced today that independent investigators presented new data supporting AmBisome (liposomal amphotericin B), the company s proprietary anti-fungal product. AmBisome is cleared for use in the United States as empirical therap
News & Assignment Editors/Health & Medical Writers ADVISORY...for 11:00 a.m., Sunday (Dec. 7) A new clinic that reaches out to the underserved residents of one of San Francisco s most blighted neighborhoods will officially open at Glide Memorial United Methodist Church Sunday. Media Are Invited to Cover: Sunday
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Dec. 4, 1997--Thousands of people responded to the offer of a free Home Access(R) Express(TM) HIV test as part of a special 24-hour World AIDS Day observance conducted by Home Access Health Corporation, the leader in telemedicine. In just 24 hours, the Company received nearly $10
FOSTER CITY, Calif.--(BW HealthWire)--Dec. 4, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) today announced an expanded access program for PREVEON(TM) (adefovir dipivoxil) for people with advanced HIV infection in the United States who have limited treatment options. PREVEON, formerly referred to as adefovir dipivoxil o
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Dec. 1, 1997-- The first published account of national HIV seroprevalence and demographic data among home test users was issued today by Home Access Health Corporation, the only company that provides an over-the-counter, FDA approved HIV at-home test available nationwide in more
BUSINESS WIRE; Friday November 28, 9:36 am Eastern Time
SAN FRANCISCO--(BUSINESS WIRE)--Nov. 28, 1997--To commemorate World AIDS Day, the San Francisco AIDS Foundation is re-launching its newly expanded and graphically enhanced web site at www.sfaf.org, featuring more than 400 original articles, reports and images. The San Francisco AIDS Foundation s newly expanded and enha
BUSINESS WIRE; Wednesday November 26, 3:46 pm Eastern Time
ATLANTA--(BUSINESS WIRE)--Nov. 26, 1997--Georgia has the tenth highest number of children with AIDS in the country, 176, since 1980. Ninety-one percent of these children contracted the HIV virus from their mother during pregnancy, birth or through breastfeeding. Give Children Hope in a World with AIDS, is the theme of
SACRAMENTO, Calif.--(BW HealthWire)--November 26, 1997--In recognition of World AIDS Day and its focus on children this year, State Health Director Kim Belshe Wednesday announced that the Department of Health Services is collaborating with the federal Health Care Financing Administration (HCFA) to develop and distribut
SEATTLE--(BUSINESS WIRE)--Nov. 26, 1997--The attached editorial was written by Dr. Maxine Hayes, assistant secretary for community and family health, state Department of Health. On December 1st, we commemorate the 9th annual World AIDS Day. The day was set forth by the Joint United Nations Program on HIV/AIDS to increa
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 November 1997.
(ADVANCE) SACRAMENTO, Calif.--(BW HealthWire)--Dec. 1, 1997-- While recent advances in treatment have given new hope to many people living with HIV and AIDS, prevention is still the most effective weapon in the fight against AIDS. Do you really know the facts about HIV/AIDS? Put yourself to the test and find out. 1
MENLO PARK, Calif.--(BW HealthWire)--Nov. 25, 1997--SEQUUS Pharmaceuticals, Inc. (NASDAQ:SEQU) today announced the signing of an exclusive agreement with CritiCare Laboratories Pvt. Ltd. for the marketing, sales and distribution of AMPHOCIL in India , Bangladesh ,
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 24, 1997.
PALO ALTO, Calif.--(BUSINESS WIRE)--Nov. 24, 1997--Sun Microsystems, Inc. is providing the technological backbone for the NAMES Project Foundation s massive undertaking. The world s largest community art project and AIDS memorial is available for viewing at http://www.aidsquilt.org. The names and images which make up t
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
LAVAL, QUEBEC--(BUSINESS WIRE)--Nov. 21, 1997--BioChem Pharma Inc. (NASDAQ: BCHE; Montreal Exchange, Toronto Stock Exchange: BCH) announced today that the European Union s Committee for Proprietary Medicinal Products (CPMP) this week recommended the approval of Combivir , the first tablet to combine two anti-retrovi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday November 20, 2:08 pm Eastern Time
BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Nov. 20, 1997--Continuing its support of AIDS awareness, Playboy TV will air Doin it Right, the first TV special on heterosexual HIV/AIDS prevention, on World AIDS Day, Dec. 1. In keeping with the day s global theme, the program will also air on Playboy TV networks in the
Business Editors, Health & Medical Writers ADVISORY...for Dec. 1 (Monday) (BUSINESS WIRE)--WHAT: In observance of World AIDS Day on December 1st, Home Access Health Corporation will offer free Home Access(R) Express(TM) HIV tests to individuals who want to get tested. (There is a $6.00 shipping and handling fee.)
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 17, 1997.
SAN FRANCISCO--(BUSINESS WIRE)--Nov. 17, 1997--Health care workers are often exposed through occupational accidents to HIV or hepatitis and other blood borne diseases. Studies have found that prompt treatment for exposures can help to reduce the number of persons who actually become infected from these accidents. No
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 17 November 1997.
(ADVANCE) SAN FRANCISCO--(BUSINESS WIRE)--Nov. 17, 1997--Health care workers are often exposed through occupational accidents to HIV or hepatitis and other blood borne diseases. Studies have found that prompt treatment for exposures can help to reduce the number of persons who actually become infected from these accide
VANCOUVER, Wash.--(BUSINESS WIRE)--Nov. 17, 1997--Today, Saliva Diagnostic Systems, Inc. (SDS) (Nasdaq: SALV) announced it has signed an agreement with BioChem ImmunoSystems, Inc. the diagnostics subsidiary of BioChem Pharma Inc. (Nasdaq:BCHE)(TSE/ME: BCH), enhancing its ability to market and sell its products worldwid
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, November 24, 1997.
MENLO PARK, Calif--(BUSINESS WIRE)--Nov. 24, 1997-- Informix Software, Inc., (NASDAQ:IFMX) the leading provider of innovative database technology, and The NAMES Project Foundation, today announced the AIDS Memorial Quilt web site, a virtual display of over 70,000 names and over 43,000 images that make up the AIDS Memor
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday November 13, 10:53 am Eastern Time
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Nov. 13, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with Longs Drug Stores, a privately held chain with stores located in California, Hawaii
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 13 November 1997.
OAKLAND, Calif.--(BW HealthWire)--Nov. 13, 1997--In a rapidly changing medical field -- the care of HIV patients -- Kaiser Permanente is striving to reach out to the community by sponsoring its second annual town hall meeting on HIV: HIV Care 2000. The program will highlight some of the changes that have taken place at
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 13 November 1997.
STANFORD, Calif.--(BW HealthWire)--Nov. 13, 1997--The following is an analysis by Henry I. Miller of the FDA reform bill passed by Congress on November 9. Henry I. Miller, M.D., is a Senior Research Fellow at Stanford University s Hoover Institution, and former senior FDA official (1979-94), whose research focuses on F
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 November 1997
BOUNTIFUL, Utah--(BW HealthWire)--Nov. 12, 1997--Specialized Health Products International Inc. (NASDAQ:SHPI) today announced its wholly-owned subsidiary, Specialized Health Products Inc. ( SHP ), has signed a national Distribution Agreement with Alliance Medical ( Alliance ) to market and sell SHP s ExtreSafe(R) lance
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday November 10, 10:00 am Eastern Time
REHOVOT, Israel--(BW HealthWire)--Nov. 10, 1997--Shiloov Medical Technologies Ltd. announced today that the Mexican Ministry of Health has approved the use of the HIV ShiloovTube(TM) as a blood pre-treatment device that improves the detection of HIV, the virus that causes AIDS infection. Shiloov plans to begin marketin
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday November 4 4:21 PM EST
SAN DIEGO--(BUSINESS WIRE)--Nov. 4, 1997--Vical Inc. (Nasdaq:VICL) announced today the signing of an agreement granting Merck & Co. , Inc. (NYSE:MRK) certain rights to develop and market therapeutic vaccines against the human immunodeficiency virus (HIV) and the hepatitis B virus (HBV) using Vical s patented naked
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.
(BUSINESS WIRE)--President and Vice President go online to talk face to face with kids in hospitals across the country and announce 1998 expansion of STARBRIGHT World *T WHO: President Clinton and Vice President Gore will join STARBRIGHT Chairman Steven Spielberg and STARBRIGHT Capital Campaign Chairman General H. Norm
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Oct. 30, 1997--Shaman Pharmaceuticals, Inc. (NASDAQ:SHMN) announced today the results of a Phase II double-blind, randomized, placebo-controlled pilot study that examined Provir s ability to treat diarrhea in patients with AIDS. The study was a five-day, in-hospital trial t
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 30 October 1997.
SAN DIEGO--(BUSINESS WIRE)--Oct. 30, 1997--Epimmune Inc., a wholly owned subsidiary of Cytel Corp. (NASDAQ:CYTL), Thursday announced the publication of three papers in peer-reviewed scientific journals that demonstrate the ability of Epimmune s proprietary T-cell epitope selection technology to identify relevant diseas
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday October 28 5:02 PM EST
BERKELEY, Calif.--(BW HealthWire)--Oct. 28, 1997--New research shows that a combination of urine and blood-based tests can detect antibodies to the human immunodeficiency virus, type 1 (HIV-1) with greater sensitivity than can be achieved by either test alone. Results of clinical trials reported by researchers from Cal
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
HICKORY, N.C.--(BW HealthWire)--Oct. 28, 1997--American Diversified Group (OTC BB:ADGI) Monday announced that it has arranged for the initial shipment of HIV Test Kits to the National Blood Bank of Mali pursuant to an order announced on Oct. 14, 1997. ADGI has confirmed that the 2,500 HIV Test Kits, part of an order fo
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 23 October 1997.
WILMINGTON, De.--(BW HealthWire)--Oct. 23, 1997-- VIMRX Pharmaceuticals Inc. (NASDAQ: VMRX) today announced that it has initiated a Phase II clinical trial to evaluate VIMRxyn(R) (synthetic hypericin) as a topically applied, light-activated therapy for specific skin diseases including psoriasis, cutaneous T-cell lympho
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 22 October 1997
ALAMEDA, Calif.--(BW HealthWire)--Oct. 22, 1997--Calypte Biomedical Corp. today announced the completion of a private placement of common stock which raised over $10 million. Pacific Growth Equities acted as sole placement agent on the offering. Following this transaction, the company has 13.1 million weighted average
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 21 October 1997.
STANFORD, Calif.--(BW HealthWire)--Oct. 21, 1997--HIV-positive individuals can get a new test at Stanford University Medical Center to determine whether the strain of virus in their blood is resistant to one or more antiviral drugs. The test, called HIV antiviral resistance testing by genotyping, involves genetic analy
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 21 October 1997.
CAMBRIDGE, Mass.--(BW HealthWire)--Oct. 21, 1997-- Procept Inc. (NASDAQ:PRCT) today announced the completion of its second Phase I safety trial in London, United Kingdom with the company s lead drug candidate, PRO 2000 Gel. The product is designed to be used for the prevention of human immunodeficiency virus type 1 (HI
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
CAMBRIDGE, Mass.--(BW HealthWire)--Oct. 15, 1997--Procept Inc. (Nasdaq:PRCT) announced today that it has been issued Patent 5,677,343 covering its PRO 2000 gel, a topical microbicide it is developing as a chemical barrier to prevent HIV infection. This is the second patent the company has been issued relating to the pr
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday October 14 12:36 PM EDT
HICKORY, N.C.--(BW HealthWire)--Oct. 14, 1997--American Diversified Group (OTC BB:ADGI) Tuesday announced that it has received an initial order for approximately 4,500 HIV test kits from its representative, PERGUE S.A.R.L., for the National Blood Bank of Mali . This order is being shipped in October 1997, and is part o
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 13 October 1997.
PALO ALTO, Calif.--(BW HealthWire)--Oct. 13, 1997--The blood supply has been a chief pathway for the spread of AIDS. To protect it, the American Red Cross long ago started testing the blood of all volunteer donors. But in poor regions of the world, such vigilant screening is out of the question. In parts of Africa, for
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday October 22 7:11 PM EDT
(BUSINESS WIRE)-- The LiPA HIV-1 RT test can predict when a particular drug will stop working and enable doctors to switch patients to another treatment. It will also allow them to put newly-diagnosed patients on the most suitable mediation from the start. Watch streaming video which discusses how the LiPA HIV-1 RT tes
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.
SOUTHBORO, Mass.--(BW HealthWire)--Oct. 8, 1997--A recent September issue of Cell reports exciting news of a novel anti-HIV-1 strategy involving sophisticatedly engineered viruses that seek and destroy human HIV-1 infected cells only, then move on to seek out and destroy other HIV-1 infected cells. (Mebatsion et al., 1
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.
SAN FRANCISCO--(BW HealthWire)--Oct. 8, 1997--After several attempts to secure approval, funding, and the government-supplied marijuana required for a study of the effects of marijuana on HIV-infected patients, a group of UCSF physician-scientists and the Community Consortium has been successful in presenting a clinica
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 8 October 1997.
OAKLAND, Calif.--(BW HealthWire)--Oct. 8, 1997--Although new and more promising drugs are helping to make AIDS into a chronic, and not always fatal disease, living with HIV is still quite difficult. That s why a new workshop at Kaiser Permanente aims to help people with HIV deal with their illness more effectively. No
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday October 2 8:04 AM EDT
COSTA MESA, Calif.--(BW HealthWire)--Oct. 2, 1997--Adding to mounting evidence of selenium s health benefits, this week s Journal of Acquired Immune Deficiency Syndrome reported that HIV-infected men and women with selenium deficiency were 19.9 times more likely to die of AIDS than those with adequate selenium levels.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday October 1 10:16 AM EDT
TORONTO--(BW HealthWire)--Oct. 1, 1997-- AmBisome(R) Superior to Conventional Amphotericin B in Reducing Proven Treatment-Emergent Fungal Infections, Nephrotoxicity and Infusion-Related Toxicity A new liposomal antifungal agent is as effective and safer than conventional therapy for the treatment of presumed fungal inf
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 29 September 1997.
ADVANCE...for release 9 a.m. PDT Sept. 29 Note: To coincide with presentation at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (ADVANCE) TORONTO--(BW HealthWire)--Sept. 29, 1997--In a retrospective study of 136 HIV-infected patients who took potent protease inhibitor therapy, more th
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 29 September 1997
TORONTO--(BW HealthWire)--Sept. 29, 1997--SENTRY ANTIMICROBIAL SURVEILLANCE data confirm need for new antibiotics and better-focused local infection control practices. Results from the first seven months of SENTRY ANTIMICROBIAL SURVEILLANCE(1) were reported today during the 37th Interscience Conference on Antimicrobial
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 29 September 1997.
BERKELEY, Calif.--(BW HealthWire)--Sept. 29, 1997--New research by XOMA Corporation (NASDAQ:XOMA) further demonstrates the breadth of the company s BPI (bactericidal permeability-increasing protein) anti-infective development platform. Company scientists have demonstrated that formulations of the BPI-derived compound r
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
VANCOUVER, Wash.--(BUSINESS WIRE)--Sept. 29, 1997-- Studies recently completed by independent investigators in Malaysia and Vietnam using Hema-Strip HIV, a rapid whole blood test developed by Saliva Diagnostic Systems, Inc. (Nasdaq: SALV), indicate the device is equivalent in sensitivity and specificity to other, widel
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday September 29 9:40 AM EDT
LAVAL, Quebec--(BUSINESS WIRE)--Sept. 29, 1997--BIOCHEM PHARMA(ME, TSE:BCH., NASDAQ:BCHE.) BioChem Pharma Inc. announced today that its licensee Glaxo Wellcome Inc. has received clearance from the US Food and Drug Administration ( FDA ) to market Combivir , t
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 September 1997.
CHICAGO--(BW HealthWire)--Sept. 27, 1997--Home Access Health Corp. supports the U.S. Food and Drug Administration s ( FDA ) prompt action in warning the public regarding the illegitimate sale of the Lei-Home Access HIV test on the Internet. Home Access Health is the only company currently selling an FDA-approved HIV at
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 18 September 1997.
ALAMEDA, Calif.--(BW HealthWire)--Sept. 18, 1997--Calypte Biomedical Corp. (NASDAQ:CALY) announced today that Cambridge Biotech Corp. has received official notice from the FDA that the agency has completed its review of the Cambridge Biotech/bioMerieux Vitek application supplement for its Human Immunodeficiency Virus T
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 15 September 1997.
SAN DIEGO--(BW HealthWire)--Sept. 15, 1997--Vical Inc. (Nasdaq:VICL) announced today the signing of an agreement granting Merck & Co. , Inc. (NYSE:MRK) certain rights to use Vical s naked DNA technology to deliver certain growth factors. The agreement resulted in an initial payment to Vical of $2 million and has a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 September 1997
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Sept. 12, 1997-- Students on California college campuses now have instant toll-free access to purchase either Home Access Express(R) (results in 3 days) or Home Access(R) (results in about a week), both products allow people to anonymously test for HIV within the privacy of their
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 10 September 1997.
HICKORY, N.C.--(BUSINESS WIRE)--Sept. 10, 1997--American Diversified Group Inc. (OTC BB:ADGI) Wednesday announced that the National Blood Bank of Mali has requested that ADGI ship for approval and sale HIV Test Kits, which will be shipped to the National Blood Bank within 10 days. The HIV Test Kits are part of the rec
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday September 9 5:39 PM EDT
SANTA MONICA, Calif.--(BUSINESS WIRE)--Sept. 9, 1997-- Rick Weiss New Hope Apartments to Provide the City s First-Ever Long-Term Assisted Housing For Individuals & Families in Need Nonprofit AIDS service organization Project New Hope will hold a groundbreaking ceremony for the Rick Weiss New Hope Apartments on Frid
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 9 September 1997.
(ADVANCE) SAN FRANCISCO--(BW HealthWire)--Sept. 9, 1997-- Tuberculosis (TB) control policies should provide reasonable access to housing, psychiatric and substance abuse care for patients who persistently do not adhere to their TB treatment, according to an analysis of California s TB control policy published in this w
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 9 September 1997.
LAS VEGAS--(BW HealthWire)--Sept. 9, 1997-- Correcting Misleading Laboratory Reporting Could Lead to Use of New Diagnostics, Anti-Cortisol Treatments A study published in the September 1997 issue of Psychoneuroendocrinology, Oxford, U.K., reveals information about the role of cortisol in health and disease. Cortisol (
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
STANFORD, Calif.--(BW HealthWire)--Sept. 11, 1997--The tuberculosis vaccine known as BCG has been given to more people worldwide than any other vaccine, yet its effectiveness remains controversial. A new analysis by researchers at Stanford School of Medicine suggests that the bacterial strains used in current BCG vacci
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 8 September 1997.
EMERYVILLE, Calif.--(BW HealthWire)--Sept. 8, 1997--Chiron Corporation (NASDAQ:CHIR) announced today the appointment of Margaret A. Liu, M.D., as vice president of vaccines research. Dr. Liu will be responsible for all Chiron s U.S. vaccine research including work on DNA-based vaccines. She will report directly to Lewi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 5 September 1997.
TULSA, Okla.--(BUSINESS WIRE)--Sept. 5, 1997--Maxxon Inc. (OTC BB: MXON) William Robinson, vice president, announced today the delivery of the engineered prototype of the Maxxon Safety Syringe(TM). Texas Applied Biotechnology Services president, Ms. Joyce Heinrich, informed Robinson that the prototype syringe would be
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 5 September 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Sept. 5, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with CVS Corporation (NYSE:CVS), the nation s largest chain drug store company. By Octob
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 29 August 1997
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 29, 1997--Home Access Health Corp., maker of Home Access Express(R) HIV test system, will offer a free HIV test kit to consumers who have purchased Confide(R) and are unable to obtain their test result as a result of Johnson & Johnson s June 26, 1997 announcement that it
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday August 28 12:15 PM EDT
TORONTO--(BUSINESS WIRE)--Aug. 28, 1997--PACE (CANADIAN DEALING NETWORK PACL.) The Pace Corporation today announced that the World Health Organization s Collaborating Centre on AIDS, the Program for Appropriate Technology in Health (PATH), has completed tests of the Company s rapid HIV-LOGIC(TM) test kit. The PATH repo
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 26 August 1997.
MCLEAN, Va.--(BUSINESS WIRE)--Aug. 26, 1997--APACHE Medical Systems, Inc. (NASDAQ:AMSI) today announced an agreement with the Health Council of South Florida to provide services related to the Medicaid Outcomes Health Management Initiative ( the HMI Project ) for HIV/AIDS patients. The HMI Project is designed to improv
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 25 August 1977.
SAN FRANCISCO--(BW HealthWire)--Aug. 25, 1997--In the nation s largest and longest study of heterosexual HIV transmission, UC San Francisco researchers found that the practice of anal sex, lack of condom use, injection drug use and the presence of a sexually transmitted disease (STD) are the strongest predictors of inf
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 21 August 1997.
WASHINGTON--(BUSINESS WIRE FEATURES)--Aug. 21, 1997--For some teenagers, the appeal of helping others is more enticing than watching TV, surfing the Net or playing with friends. A dedicated group of 22 such young people from across the country have become role models for both adults and adolescents in the fight against
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday August 27 12:59 AM EDT
STAUFENBERG, Germany--(BW HealthWire)--Aug. 26, 1997--Bonito Industries Inc. (OTC BB:BNTO) Tuesday announced that it has entered into an agreement with Laboserv s.r.l. of Germany for the acquisition of the exclusive distribution rights for the sale of a new HIV home detection kit. Preliminary testing of the HIV detecti
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 20 August 1997.
VANCOUVER, Wash.--(BUSINESS WIRE)--Aug. 20, 1997-- - Saliva Diagnostic Systems to begin aggressive sales campaign for Saliva-Strip(TM) HIV - A rapid test that uses saliva to detect HIV antibodies will be marketed for professional use in the United Kingdom , medical diagnostics maker Saliva Diagnostic Systems, Inc. (Nas
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.
LOS ANGELES, Calif.--(BUSINESS WIRE)--Aug. 19, 1997--Recommitting itself to research and public education about a potentially deadly organism, Metropolitan Water District s board of directors today authorized $442,000 for a third year of its Cryptosporidium Action Plan. Around-the-clock monitoring of our filtration pla
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.
FRANKFURT, Germany--(BW HealthWire)--August 19, 1997--Behring Diagnostics, a member of the Hoechst Group, and Boehringer Mannheim today announced that they have signed a non-exclusive worldwide licensing agreement with Abbott Laboratories for patents and patent applications covering human immunodeficiency virus 1 group
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 19 August 1997.
ALBUQUERQUE, N.M.--(BW HealthWire)--Aug. 19, 1997--Cell Robotics International Inc. (OTC: CRII) announced that it has received clearance from the FDA to market its Lasette(TM) laser finger perforator. The Lasette is a small, hand-held battery-operated laser device that produces a small hole in the finger with a single
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
ARDEN HILLS, Minn.--(BW HealthWire)--August 14, 1997--GalaGen Inc. (Nasdaq: GGEN) today announced that it has initiated a multi-center Phase II clinical trial of Diffistat-G(TM), the Company s polyclonal antibody drug for the treatment of antibiotic-associated diarrhea, a life-threatening illness caused by the pathogen
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 13 August 1997.
FORT LAUDERDALE, Fla.--(BW HealthWire)--Aug. 13, 1997--Ft. Lauderdale-based Page & Associates recently began offering the first free Viatical Settlement Representative certification course in the United States . This course was designed to help educate people wanting to become representatives in the ever growing vi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 13 August 1997, 10:02 Pacific
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 13, 1997--Home Access Health Corp., maker of Home Access Express(R) HIV test system, will offer a free HIV test kit to consumers who have purchased Confide(R) and are unable to obtain their test result as a result of Johnson & Johnson s June 26, 1997 announcement that it
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday August 12, 1997 4:50 PM EDT
STANFORD, Calif.--(BUSINESS WIRE)--Aug. 12, 1997--Three years ago, the Positive Care Clinic opened its doors to HIV patients in a former general medicine ward at Stanford University Hospital. Since then, the epidemic has entered a new era, with many patients now experiencing AIDS as a manageable, chronic disease. The c
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 7 August 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--Aug. 7, 1997--Home health care consumers searching the Internet should be aware of the marketing activities of unapproved and illegal HIV home test kits according to Home Access Health Corporation, the leader in telemedicine, providing fast and convenient at-home medical testing
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 August 1997.
BOULDER, Colo.--(BW HealthWire)--Aug. 6, 1997--NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) today announced that the Korean Ministry of Health has granted marketing approval for AmBisome, as a first line, or primary therapy, for systemic fungal infections, including Candidiasis, Histoplasmosis, Cryptococcus and Aspergil
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
BURLINGTON, N.C.--(BUSINESS WIRE)--August 5, 1997--Laboratory Corporation of America(TM) Holdings (LabCorp(TM))(NYSE: LH) today announced that it is the first commercial reference laboratory to offer HIV genotyping using GeneChip(R) DNA probe arrays and polymerase chain reaction (PCR) based assays. GeneChip Probe array
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 5 August 1997
OLYMPIA, Wash.--(BUSINESS WIRE)--Aug. 5, 1997--More Washington children now are protected against hepatitis B than ever before according to the state Department of Health. A national immunization survey released last week by the Centers for Disease Control and Prevention indicates that the hepatitis B immunization rate
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 4 August 1997.
NEW YORK--(BUSINESS WIRE)--August 4, 1997--In AIDS-ravaged Africa, a controversial drug study is leaving pregnant women at risk and stirring outrage. VIBE contributor Harry Allen investigates the issue in the Fourth Anniversary special September Juice issue, on sale August 5. As President Clinton publicly apologizes to
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday August 12, 1997 - 12:02 PM EDT
DEERFIELD, Ill. and BOULDER, Colo.--(BW HealthWire)-- Aug. 12, 1997-- First Liposomal Amphotericin B Indicated for Empirical Therapy for Presumed Fungal Infections in Immunocompromised Patients Fujisawa USA , Inc. and NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) announced today that the U.S. Food and Drug Administration
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 31 July 1997
BOYNTON BEACH, Fla.--(BW HealthWire)--July 31, 1997--Pure H20 Bio-Technologies (PHBT) reported that its water disinfection/purification systems killed Cryptosporidium, a deadly water-borne disease that has already killed more than 400 Americans and has caused 370,000 people to become ill to date. No other water purific
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 30 July 1997.
MENLO PARK, Calif.--(BUSINESS WIRE)--July 30, 1997--SEQUUS Pharmaceuticals, Inc. (Nasdaq: SEQU) announced that the regulatory authorities in Australia and New Zealand have granted marketing clearance for its proprietary anticancer drug, DOXIL , in the treatment of Kaposi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 28 July 1997.
NEW YORK--(BUSINESS WIRE)--July 28, 1997-- NY State Commonwealth Retirement Fund, together with Mothers Voices, other prominent AIDS organizations, and NYC Council call for the availability of 1592, a powerful new drug in the treatment of AIDS State Comptroller H. Carl McCall, the sole trustee of the New York State Com
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 28 July 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--July 28, 1997--Home Access Health Corporation, the telemedicine leader in providing fast and convenient at-home medical testing and consultation, has announced a retail distribution agreement with Thrifty PayLess drug stores, a subsidiary of the Rite Aid Corporation (NYSE:RAD). P
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 21 July 1997.
SAN FRANCISCO--(BW HealthWire)--July 21, 1997--Analysis of treatment and services data from 11 recent qualitative focus groups of San Francisco AIDS Foundation (SFAF) clients indicated three main trends: clients are generally gaining access to new treatments and have a high level of access to primary medical care, howe
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 21 July 1997.
LONGMONT, Colo.--(BUSINESS WIRE FEATURES)--July 21, 1997-- Guides for Living announced today the release of the third edition of HIV /AIDS Resources. This award-winning directory, touting a staggering 29,500 listings, is the most comprehensive nationwide compilation of HIV and AIDS service providers available. The dire
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 18 July 1997.
SAN FRANCISCO--(BW HealthWire)--July 18, 1997--The UC San Francisco Medical Center ranks among the country s 10 best hospitals, according to a new survey conducted by U.S. News & World Report. The UCSF-affiliated San Francisco General Hospital ranks as the best center for AIDS care. Results of the survey of America
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 July 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--July 17, 1997--People are more likely to purchase a home access HIV test kit if the kits are placed on store shelves instead of behind a pharmacy counter, according to the results of a survey released today by Home Access Health Corporation, makers of the Home Access(R) HIV home
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.
SAN DIEGO, California--(BW HealthWire)--July 16, 1997--IDEC Pharmaceuticals (Nasdaq:IDPH) today announced the receipt of notices of allowance for three United States patents. The first allowed patent covers the company s IDEC-C2B8 (rituximab) antibody, now known as RITUXAN(TM), which is the subject of Biological Licens
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.
SILVER SPRING, Md.--(BW HealthWire)--July 16, 1997--NeXstar Pharmaceuticals, Inc. (NASDAQ:NXTR) and Fujisawa USA , Inc. announced that the U.S. Food and Drug Administration ( FDA ) Antiviral Drug Products Advisory Committee voted unanimously today that AmBisome(R) is safe and effective as empirical therapy for presumed
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997.
BURLINGAME, Calif.--(BW HealthWire)--July 16, 1997--KOSAN Biosciences Inc., a biotechnology company based in Burlingame, announced today that it has received a Phase I Small Business Innovative Research (SBIR) grant from the National Institute of Allergy & Infectious Diseases (NIAID) to pursue research in Combinato
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 16 July 1997
NEWTOWN, Pa.--(BW HealthWire)--July 16, 1997--Scott-Levin, a leading provider of consulting services to the pharmaceutical industry, today introduced the HIV Therapy Audit, the first product of its kind and the only projectable database of patients seeking treatment due to their HIV status. While the US Centers for Dis
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 July 1997.
CLAREMONT, Calif.--(BW HealthWire)--July 14, 1997--New data reported in the New England Journal of Medicine indicates that sustained-release ganciclovir (Cytovene; Roche Laboratories ) intraocular implant ( Vitrasert ; Chiron Vision) significantly delays the onset of cytomegalovirus
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 10 July 1997.
REMINDER...for Thursday 7/10-Sunday 7/13 --(BW HealthWire)-- IL-2 is a human cytokine that has been found to stimulate the immune system and provide therapeutic benefit in patients with certain cancers and HIV. Oncologists are convening in San Francisco for the First Proleukin International Congress to present research
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday July 8 1:51 PM EDT
SAN FRANCISCO--(BW HealthWire)--July 8, 1997--Researchers at the University of California San Francisco have received funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, for a period of four years to focus on new and innovative ways to study how inf
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday July 8 4:01 PM
McLEAN, Va.--(BUSINESS WIRE)--July 8, 1997--APACHE Medical Systems, Inc. (NASDAQ:AMSI) today announced that the Centers for Disease Control and Prevention (CDC) has extended their Cooperative Agreement with APACHE s Health Research Network Division (HRN) through 2001. HRN has been performing longitudinal data collectio
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 July 1997
SANTA MONICA, Calif.--(BW HealthWire)--July 8, 1997--American Pharmaceutical Partners and Glaxo Wellcome Inc. announced an agreement whereby Glaxo Wellcome will manufacture and supply American Pharmaceutical Partners with 500 mg and 1000 mg formulations of lyophilized acyclovir.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 2 July 1997
SAN FRANCISCO--(BW HealthWire)--July 1, 1997--The HIV -infected urban poor should be given access to protease inhibitors , say a group of UC San Francisco researchers specializing in studies of the homeless and marginally housed. Many homeless can adhere to the complex treatment regimens required and not to make them a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 July 1997.
OLYMPIA, Wash.--(BUSINESS WIRE)--July 1, 1997--Until a water filtration system is constructed, homes and businesses connected to the Aberdeen water supply will be advised to boil drinking water when storms or other factors threaten the city s drinking water supply, health officials announced at a meeting last night.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN DIEGO and SOUTH SAN FRANCISCO--(BW HealthWire)--July 25, 1997-- IDEC Pharmaceuticals Corporation (NASDAQ:IDPH) and Genentech , Inc. (NYSE:GNE) today announced that Rituxan(TM) (Rituximab), also known as IDEC-C2B8, a monoclonal antibody, was recommended unanimously for marketing clearance by the Biological Response
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 27 June 1997.
LAVAL, Quebec--(BUSINESS WIRE)--June 27, 1997--BioChem Pharma Inc. (NASDAQ: BCHXF; Montreal Exchange, Toronto Exchange: BCH) announced today that a large U.S. study of children with symptomatic HIV disease has been stopped because an analysis of the data revealed that patients treated with
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 27 June 1997
SACRAMENTO, Calif.--(BW HealthWire)--June 27, 1997--In conjunction with National HIV Testing Day, State Health Director S. Kimberly Belshe announced that HIV counseling and testing at state-funded test sites increased by 29 percent among Californians who are most at risk for contracting the virus, according to new trac
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997
SAN FRANCISCO--(BW HealthWire)--June 26, 1997--The San Francisco AIDS Foundation s English, Spanish and Filipino AIDS information and referral hotline will expand beyond Northern California to answer calls from the entire state starting July 1, providing all Californians with one consistent source of AIDS information .
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997
HOFFMAN ESTATES, Ill.--(BW HealthWire)--June 26, 1997--Home Access Health Corporation is issuing the following statement from president Richard A. Quattrocchi: Home Access HIV testing is an important testing alternative for people. We will continue to provide consumers fast, accurate and convenient home medical test
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday June 26 11:39 AM EDT
ATLANTA--(BUSINESS WIRE)--June 26, 1997--The U.S. Centers for Disease Control and Prevention (CDC) announced today a new plan to recognize outstanding HIV/AIDS prevention programs in the workplace and is seeking nominations for the awards. CDC will bestow National Business and Labor Awards for Leadership on HIV/AIDS to
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 26 June 1997.
ROCKPORT, Mass.--(BUSINESS WIRE FEATURES)--June 26, 1997-- Centers for Disease Control and Prevention (CDC) Director David Satcher, challenged by scientists, black leaders, and citizen groups concerned about vaccination risks, declined to discuss AIDS as a possible outcome of contaminated vaccines with the author of a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 25 June 1997.
LOS ANGELES--(BW HealthWire)--June 25, 1997--A patent on the use of 200-plus antibody therapies specifically to treat HIV/AIDS has been awarded to scientist Allen D. Allen, who heads CytoDyn, a research firm based in Los Angeles. The patent, to be published by the U.S. Patent and Trademark Office on July 29, 1997, will
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 24 June 1997
(ADVANCE) SAN FRANCISCO--(BW HealthWire)--June 24, 1997--In response to new information in the treatment of HIV disease, updated guidelines have been published by an international panel of AIDS experts to advise caregivers and patients as they deal with the ever-changing state-of-the-art in therapies for HIV disease.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN FRANCISCO--(BUSINESS WIRE)--June 24, 1997--The U.S. Conference of Mayors (USCM), at its annual meeting today; approved a bipartisan resolution -- co-sponsored by Democratic Mayor Willie Brown of San Francisco and Republican Mayor Richard Riordan of Los Angeles -- urging U.S. Secretary of Health and Human Services D
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN ANTONIO--(BUSINESS WIRE)--June 23, 1997--ILEX Oncology, Inc. (NASDAQ: ILXO) today announced that the U.S. Food and Drug Administration s ( FDA ) Oncologic Drugs Advisory Committee found that there was not substantial evidence that Zyrkamine(R) (mitoguazone dihydrochloride for injection) was effective as a second-li
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 23 June 1997
SAN FRANCISCO--(BW HealthWire)--June 23, 1997--Does physician-assisted suicide end the suffering of people who are terminally ill? Or is it a slippery slope leading to unnecessary deaths of patients unable to pay for continued care, or who are considered too heavy a burden? The latest issue of the Western Journal of Me
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 17 June 1997
OLYMPIA, Wash.--(BUSINESS WIRE)--June 17, 1997--The license of Seattle physician Dr. Timothy J. Smith (MD18800) will be indefinitely suspended July 1 by the state Medical Quality Assurance Commission. Beginning January 1, 1998, Smith will be allowed to practice administrative medicine, peer and chart review, teaching a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 June 1997.
MINNEAPOLIS--(BW HealthWire)--June 12, 1997--AMUR Pharmaceuticals Inc. today announced the discovery of a new class of human steroid conjugates. Six new steroid conjugates have been identified, the first of which is DHEA-PC (Dehydroepiandosterone-phosphocoline). Company researchers have synthesized DHEA-PC and have con
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 12 June 1997.
SACRAMENTO, Calif.--(BW HealthWire)--June 12, 1997--The 10 retired teachers gathered in a small Sacramento meeting room faced a daunting task. Although they possessed no medical training, the teachers were being asked to decide what kind of treatment people with dire health conditions should receive: should an advanced
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 11 June 1997.
PORTLAND, Maine--(BW HealthWire)--June 11, 1997-- ImmuCell Corporation (Nasdaq:ICCC; BSE:IMU) announced today that its joint venture with New Jersey-based Membrex, Inc. has achieved two significant milestones relating to its Crypto-Scan(TM) water diagnostic test: 1) it has entered into an exclusive distributor relation
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 11 June 1997
TORONTO--(BUSINESS WIRE)--June 11, 1997--(TSE, VSE: NVO.) Novopharm Biotech Inc. (TSE & VSE:NVO) announced today that the company has filed an Investigational New Drug (IND) application with the Canadian Health Protection Branch (HPB) for a Phase I study of NOVOMAb-G2, a recombinant pan-carcinoma specific human ant
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 9 June 1997.
SACRAMENTO, Calif.--(BW HealthWire)--June 9, 1997--California Medical Association is pleased to announce that legislation seeking to undermine the landmark Medical Injury Compensation Reform Act (MICRA) of 1975 has been placed on the Inactive File in the California Assembly. The action ensures that the Assembly will no
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 9 June 1997.
NEW YORK--(BUSINESS WIRE)--June 9, 1997--Advanced Plant Pharmaceuticals Inc., (OTC Bulletin Board: APPI) today announced that it has filed a total of 13 patents covering the use of ABAVCA/PERTHON, which is currently under development by the company for use in the treatment of AIDS related symptoms. The patents filed co
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 6 June 1997.
ELIZABETH, N.J.--(BW HealthWire)--June 6, 1997--Faulding Inc. s wholly owned subsidiary, Purepac Pharmaceutical Co., has received approval from the Food and Drug Administration to market acyclovir tablets, it was announced today by Richard F. Moldin, president and chief executive officer of Faulding Inc. Our 400 m
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 6 June 1997.
ISELIN, NJ--(BUSINESS WIRE)--June 6, 1997--Bio-Technology General Corp. (NASDAQ:BTGC) today announced that the District Court in Tel-Aviv yesterday dismissed the appeal filed by Biogen, Inc., of a decision by the Israeli Commissioner of Patents which granted BTG s Israeli subsidiary a compulsory license under Biogen s
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 5 June 1997.
SAN FRANCISCO--(BW HealthWire)--June 5, 1997--AIDS patients who are given protease inhibitors to treat their HIV infection may develop cytomegalovirus ( CMV ) retinitis following the treatment, a University of California San Francisco study has found.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 June 1997.
BOULDER, Colo.--(BW HealthWire)--June 4, 1997--NeXstar Pharmaceuticals Inc. (NASDAQ:NXTR) and Fujisawa USA Inc. announced today that the U.S. Food and Drug Administration ( FDA ) has scheduled an Antiviral Drug Advisory Committee Meeting for Wednesday, July 16 to review data supporting the New Drug Application (NDA) fo
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 June 1997.
(ADVANCE) SAN FRANCISCO--(BUSINESS WIRE)--June 4, 1997--AIDS patients who suffer from non-Hodgkin s lymphoma (NHL), a fast-growing cancer of the lymph system, can be as effectively treated with low doses of chemotherapy as the standard high doses, a multi-center study led by researchers at UC San Francisco has found.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 2 June 1997.
CAMBRIDGE, Mass.--(BW HealthWire)--June 2, 1997--Procept, Inc. (Nasdaq:PRCT) today announced the completion of its Phase I safety trial in Antwerp, Belgium with the Company s lead drug candidate, PRO 2000 Gel. The product is designed to be used for the prevention of human immunodeficiency virus type 1 ( HIV -1) infecti
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 29 May 1997.
BERKELEY, Calif.--(BW HealthWire)--May 29, 1997--This summer, U.C. Berkeley Extension offers two seminars that focus on HIV /AIDS. The purpose of the first, Clinical and Psychosocial Aspects of HIV , is to inform clinicians about the medical, psychological and social aspects of HIV disease. Participants learn critical
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 29 May 1997.
CAMBRIDGE, Mass.--(BW HealthWire)--May 29, 1997--Renowned Researcher Is 1978 Graduate of Select Harvard/MIT Program On Wednesday, June 4 from 1 to 3 p.m., Dr. David Ho, TIME magazine s 1996 Man of the Year will present the graduation address for the Harvard-MIT Division of Health Sciences and Technology (HST) at the MI
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday May 28 2:51 PM EDT
SAN FRANCISCO--(BUSINESS WIRE)--May 28, 1997--Gay male couples are often ignored in HIV prevention campaigns, according to UCSF researchers who are conducting the first study to assess reports of sexual behavior from both men in the couple. Seldom do prevention campaigns address gay men as part of a couple, said Tom Sl
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 27 May 1997.
ATLANTA--(BW HealthWire)--May 27, 1997--One-of-a-kind expo to showcase the market s latest advancements in cost saving products for confidential and reliable home diagnostic testing Answering the call within a healthcare industry that is quickly looking to the advantages and cost savings associated with home test kits,
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
NEW YORK--(BW HealthWire)--May 23, 1997--Partnership in Vision (PIV), a collaboration of leading AIDS practitioners, advocates and vision specialists, today announced the premiere of its World Wide Web site (http://www.piv.org). The site is designed as a comprehensive educational resource for people with, and at risk f
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 21 May 1997.
ROCKVILLE, Md.--(BW HealthWire)--May 21, 1997-- EntreMed Inc. (NASDAQ:ENMD) Wednesday announced successful interim results in brain cancer and Kaposi s sarcoma patients being treated with thalidomide in Phase II clinical trials . A 50-percent biological response in glioblastoma multiformae (brain cancer) patients curre
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
BOULDER, Colo.--(BW HealthWire)--May 21, 1997--NeXstar Pharmaceuticals, Inc., (NASDAQ: NXTR) announced today that the Brazilian Ministry of Health has approved AmBisome (liposomal amphotericin B) for use in the treatment of systemic, or blood-borne fungal infections. The drug will be launched shortly through the compan
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 19 May 1997.
CONCORD, Mass.--(BUSINESS WIRE)--May 19, 1997--In a move that will strengthen MGA Software Inc. s dominant presence in the clinical trial simulation market, the Company announced today the availability of ACSL BioMed 2.1. This latest version of ACSL BioMed, targeted to pharmacologists who are novice simulation software
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 16 May 1997.
STANFORD, Calif.--(BW HealthWire)--May 16, 1997--The immune system adheres to a behavioral code that demands respect for the body s healthy cells and allows attack of only cancers and harmful microbial invaders -- usually. But sometimes immune cells break the rules and turn against normal parts of the body. When this h
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 15 May 1997.
BERKELEY, Calif.--(BW HealthWire)--May 15, 1997-- XOMA Corporation (NASDAQ:XOMA) today announced that it had received a new U.S. patent (No. 5,627,153, issued May 6, 1997), directed to the use of its pharmaceutical BPI protein products to treat fungal infections. The increasing incidence of systemic fungal infections,
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 14 May 1997.
OAKLAND--(BUSINESS WIRE)--March 14, 1997--In an exhaustive study of ten years of mortality data for over 65,000 men and women, Kaiser Permanente research scientists found no statistically significant association between marijuana smoking and death. The study, entitled Marijuana Use and Mortality, is being published in
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 14 May 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--May 14, 1997--Drug stores, pharmacies and other retail outlets in Kentucky can continue to sell Home Access(R) HIV home test kits as a result of a judge s order entered in Franklin Circuit Court in Lexington, KY. The order enjoined enforcement of any Kentucky state law that would
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:13 Eastern
SAN ANTONIO, Texas/CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 12, 1997-- ILEX(TM) Oncology, Inc. and LeukoSite Inc. today announced they have formed a joint venture to develop Campath-1H, a monoclonal antibody under development for the treatment of patients with chronic lymphocytic leukemia (CLL). CLL, the most prevalent f
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:13 Eastern
NEW YORK--(BW HealthWire)--May 12, 1997-- America s No. 1 brand introduces a new condom designed to increase pleasure for both partners Safer sex may never be the same, now that TROJAN ULTRA PLEASURE(TM) latex condoms have hit the market. According to the makers of TROJAN(R), America s No. 1 condom brand, the new condo
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 12 May 1997, 10:06 Eastern
SCOTTSDALE, Ariz.--(BW HealthWire)--May 12, 1997--Bio Fluorescent Technologies Inc. s (OTC BB:BFTK) agreement dated Feb. 11, 1997 to acquire all of the assets of Immune Network Research Ltd. (INR) has since been terminated. The company is exploring the possibility of licensing or otherwise acquiring from INR its rights
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 8 May 1997, 13:27 Eastern
SAN FRANCISCO--(BW HealthWire)--May 8, 1997--Effective HIV prevention programs, such as condom distribution and needle exchange, are often overlooked by private funding agencies in the United States , according to a new UCSF survey of foundations that support HIV/AIDS prevention programs. In addition, the UCSF surv
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - MAY 8,1997 5:58 PACIFIC
CAMBRIDGE, Mass.--(BW HealthWire)--May 8, 1997-- Data Complement Anti-STD Activity Of PRO 2000 Gel Procept today announced preclinical results demonstrating the contraceptive efficacy of its PRO 2000 topical microbicide gel. In a program of late-breaking discoveries presented at the National Conference on Women and HIV
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 May 1997.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 7, 1997-- Florida-based Page and Associates, a viatical company that buys life insurance policies from terminally ill individuals, was recently licensed in California. It is the first licensed company that also offers the settlements as individual investments. Viatical compan
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 7 May 1997.
FOSTER CITY, Calif.--(BW HealthWire)--May 7, 1997-- Gilead Sciences Inc. (NASDAQ:GILD) announced today that it has begun enrolling patients in a Phase I/II study to evaluate the oral prodrug of PMPA (oral PMPA) for the potential treatment of human immunodeficiency virus (HIV) infection. This Phase I/II study is bei
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 6 May 1997.
FOSTER CITY, Calif.--(BW HealthWire)--May 6, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today that the U.S. Food and Drug Administration ( FDA ) has determined that data from a placebo-controlled Phase I/II clinical study are not sufficient to support marketing clearance of FORVADE(TM) (cidofovir gel) for th
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 6 May 1997.
Aldara(TM) 5% cream, the first new therapeutic approach to the treatment of genital and perianal warts in five years, will be available in pharmacies nationwide by June 9. It is the first patient-applied immune response modifier* for the treatment of this sexually transmitted disease (STD). Discovered, manufactured and
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN FRANCISCO--(BW HealthWire)--May 5, 1997--Researchers at the San Francisco VA Medical Center and UC San Francisco have identified a primitive protease (an enzyme that cleaves proteins), that may hold the key to a better understanding of how enzymes evolved. Enzymes, which are protein catalysts, are critical to every
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997.
VACAVILLE, Calif.--(BW HealthWire)--May 1, 1997--Biosource Technologies, Inc., was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes for Allergy and Infectious Disease to develop melanin as a novel antiinflammatory compound. Biosource has a proprietary biomanufacturing techn
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997
SEATTLE--(BUSINESS WIRE)--May 1, 1997--Providence Health System and Rosehedge, the oldest AIDS housing and health care program in Washington State, have signed a preferred provider agreement. Through this agreement Providence will expand its services to include Rosehedge as the facility of choice for patients with HIV/
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 1 May 1997.
FOSTER CITY, Calif.--(BW HealthWire)--May 1, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today that it has received marketing authorization for VISTIDE(R) (cidofovir injection) from the European Commission (EC). This authorization allows the product to be marketed in all 15 countries of the European Union as
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
NEW YORK--(BW HealthWire)--May 19, 1997--Where can you find lots of totally cool freebies like TROJAN(R) condoms , the one-and-only Date Genie who offers great dating advice, relationship surveys where your opinion about how to handle the opposite sex really counts, games that let you win fantastic prizes like a CD ste
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
BIRMINGHAM, Ala.--(BW HealthWire)--April 30, 1997-- Preclinical Studies Support Novel Immunomodulatory Therapeutic Approach BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced the initiation of a Phase I feasibility study using an oral formulation of its lead drug, BCX-34, for the treatment of HIV in combination wi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 29 April 1997.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--April 29, 1997--Stephen D. Hayter, president and chief executive officer of Empyrean Diagnostics Ltd., announces that it has obtained the exclusive marketing rights in specific areas of the world, to two new products that can help prevent the transmission of infectious disease.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SALT LAKE CITY and PHILADELPHIA--(BUSINESS WIRE)--April 28, 1997-- TheraTech Inc. (NASDAQ:THRT) and SmithKline Beecham (NYSE:SBH) Monday announced they have agreed that TheraTech will reacquire the marketing rights to its male testosterone patch in those countries where SmithKline Beecham is not currently marketing the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
NEW YORK--(BUSINESS WIRE FEATURES)--April 25, 1997--As President Clinton and Colin Powell get ready to call on America to volunteer in the President s Summit for America s Future, volunteers of the not-for-profit group New York Cares carry out this mission 365 days a year. New York Cares partnered with corporate sponso
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 25 April 1997.
QUEENS, N.Y.--(BUSINESS WIRE)--April 25, 1997--A $4.5 million gift from Bernard and Gloria Salick will endow a new tenured professorship at Queens College/CUNY, with particular focus on HIV/AIDS and cancer, and also will provide initial funding to establish a major new research center in molecular and cellular biology.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 25 8:39 AM EDT
WILMINGTON, DE--(BW Healthwire)--April 25, 1997-- -- Light-Activation Conditions Determined and Dose Ranges Selected; Company Planning Phase II Clinical Studies -- VIMRX Pharmaceuticals Inc today announced that it has successfully completed a Phase I clinical trial to evaluate VIMRxyn(R) (synthetic hypericin) as a topi
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 24 April 1997 4:40 PM EDT
NEW YORK--(BUSINESS WIRE)--April 24, 1997--Moving to protect public health under the Safe Drinking Water Act (SDWA), the United States today sued New York City for violating SDWA requirements by failing to filter drinking water from its Croton water supply. The Croton watershed, located just north of New York City, sup
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 24 April 1997.
BERKELEY, Calif.--(BUSINESS WIRE)--April 24, 1997-- XOMA Corporation (NASDAQ:XOMA) today announced that they and Pfizer Inc. (NYSE:PFE) have decided to discontinue the U.S. clinical trial of the E5(R) monoclonal antibody product as a treatment for gram-negative sepsis. Results of an interim analysis recently comple
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 18 8:01 AM EDT
SAN DIEGO--(BW HealthWire)--April 18, 1997-- GENTA INC Friday announced that an article titled BCL2 antisense therapy in patients with non-Hodgkin s lymphoma will appear in the April 19 issue of The Lancet. The article describes interim results of a Phase I/IIa clinical trial using the company s antisense drug, G3139.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday April 17 11:28 AM EDT
PORTLAND, Maine--(BW HealthWire)--April 17, 1997--ImmuCell Corporation (Nasdaq: ICCC; BSE:IMU) today announced that, under an Investigational New Drug ( IND ) application filed with the U.S. Food and Drug Administration earlier this year, it is preparing to conduct a clinical trial of its product, DiffGAM(TM) bovine an
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 April 1997.
SAN FRANCISCO--(BW HealthWire)--April 17, 1997--Behavioral scientists should broaden their research agenda to include causes of death and disability that are on the rise, such as those due to injuries and infectious disease, according to nationally known behavioral scientist Margaret Chesney, PhD, co-director of the UC
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 17 April 1997.
BLOOMFIELD, N.J.--(BUSINESS WIRE)--April 17, 1997 Scientists of Alfacell Corporation (NASDAQ: ACEL) presented today their latest research findings at the 88th American Association for Cancer Research (AACR) Annual Meeting in San Diego, further elucidating the mechanism of action of the Company s flagship product, ONCON
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 15 April 1997.
VANCOUVER, Wash.--(BUSINESS WIRE)--April 15, 1997--A rapid test for tuberculosis (TB) may be developed through a half million ECU grant awarded by the European Union to Netherlands-based KREATECH Diagnostics and SDS International Ltd., a London-based, wholly owned subsidiary of Saliva Diagnostic Systems, Inc. (Nasdaq:
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 15 April 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--April 15, 1997--Home Access Health Corporation announced a retail distribution agreement with Revco D.S., Inc. (NYSE:RXR), one of the nation s largest drug retailers. The Home Access(R) and Home Access Express(R) HIV-1 test kits are being carried by Revco Drug Stores throughout s
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 April 1997 9:01 AM EDT.
BEDFORD, Mass.--(BW HealthWire)--April 14, 1997--Eukarion, Inc. today announced that it has successfully blocked HIV-1 viral replication in living cells using a monoclonal antibody chemically modified to permit passage across cell membranes. A paper describing these results was published in the March issue of the Journ
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 14 April 1997 09:07 Eastern
EMERYVILLE, Calif.--(BUSINESS WIRE)--April 14, 1997--Chiron Corporation (NASDAQ:CHIR) announced today that it has submitted a supplemental Biological License Application (sBLA) to the United States Food and Drug Administration ( FDA ), seeking clearance to market Proleukin (aldesleukin, recombinant interleukin-2 (
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday April 11 6:58 AM EDT
PACKWOOD, Wash.--(BUSINESS WIRE FEATURES)--April 11, 1997-- In an unusual and commendable research program, an ancient herbal formula is being redeveloped that may hold the key in the treatment of AIDS. Asclepias, named after Asklepios, the Greek god of healing, is now being used in the formulation of a special herbal
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 11 April 1997.
FOSTER CITY, Calif.--(BW HealthWire)--April 11, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today data from a Phase I/II study demonstrating that the antiretroviral PMPA significantly reduced human immunodeficiency virus (HIV) RNA levels by greater than 90% after eight doses, with no significant side effects.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 10 April 1997.
LONDON and LAVAL, Quebec--(BUSINESS WIRE)--April 10, 1997-- Glaxo Wellcome plc and BioChem Pharma Inc. announce that results from a Phase III clinical study of the investigational drug, lamivudine, in hepatitis B will be presented today in London, U.K., at the annual meeting of the European Association for the Study of
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 9 April 1997.
SAN FRANCISCO--(BUSINESS WIRE)--April 9, 1997--The U.S. National Institutes of Health is awarding $4 million to fund cancer studies by researchers at the University of California San Francisco who are targeting tumor-made enzymes. These enzymes, called proteases, already have been successfully targeted with protease-in
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 9 April 1997.
San Diego, Ca--(BUSINESS WIRE)--April 9, 1997--Cytel Corporation (Nasdaq:CYTL) today announced that it is restructuring operations and spinning off its vaccine program to form a new company. The new company will focus on novel vaccines for treatment and prevention of cancer and infectious diseases, capitalizing on the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 April 1997.
MENLO PARK, Calif.--(BUSINESS WIRE)--April 8, 1997-- -- Data in April issue of peer-reviewed journal Clinical Infectious Diseases demonstrate that, as compared to amphotericin B, AMPHOTEC produces higher responses, lower mortality rates and greater renal safety in patients with invasive aspergillosis -- A retrospective
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 8 April 1997.
IRVINE, Calif.--(BW HealthWire)--April 8, 1997--Allied Biotechnology International Inc. (OTC BB: ADBI) will be offering a free seminar via telephone on Tuesday, April 8, on the benefits of using the ADBI Ozonator to eliminate dangerous bacteria and viruses, such as Hepatitis A, in food handling and processing. The trag
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 7 April 1997.
SAN FRANCISCO--(BUSINESS WIRE)--April 7, 1997--The San Francisco AIDS Foundation applauds the appointment today of Sandra Thurman as the country s new AIDS czar and calls on President Clinton to grant her the access and authority she will need to tackle the dramatic new changes in the epidemic. President Clinton must g
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 7 April 1997.
ATLANTA--(BUSINESS WIRE)--April 7, 1997--In conjunction with TBS Superstations airing of THE COMING PLAGUE, a four-hour documentary series (airing April 20 & 27) about the state of infectious diseases in our world, the network has commissioned a consumer survey conducted by Marketing & Research Resources, Inc.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 4 April 1997.
FORT LAUDERDALE, Fla.--(BW HealthWire)--April 4, 1997--Fort Lauderdale-based Page & Associates Thursday was issued Florida s first license to provide viatical settlements to Florida residents. Viatical companies provide accelerated life insurance settlements for terminally ill individuals and have been operating in
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 2 April 1997
STANFORD, Calif.--(BW HealthWire)--April 2, 1997--Researchers have identified certain T cells that suppress the reproduction of HIV carried within them. These cells, called naive CD4 T cells, mount the body s initial response to infections such as HIV, the virus that causes AIDS. About half of all CD4 T cells circulati
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 2 April 1997
OLYMPIA, Wash.--(BUSINESS WIRE)--April 2, 1997--The state Board of Health will meet April 9 to adopt new rules regarding HIV/AIDS, discuss telemedicine, vote on whether to allow optometrists to prescribe and administer non-topical drugs and hear a report on newborn screening. The meeting is open to the public. It will
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997
MENLO PARK, Calif.--(BUSINESS WIRE)--April 1, 1997--SEQUUS Pharmaceuticals, Inc. today announced results of a preclinical study comparing AMPHOTEC(TM) to amphotericin B and to alternative lipid-based formulations of amphotericin B. The study was conducted at the California Institute for Medical Research, Santa Clara Va
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997.
HUNTSVILLE, Ala.--(BW HealthWire)--April 1, 1997--CyberChemics Inc. (CCI) Tuesday announced the participation of scientists from the company, including one of its founders, Dr. David Noever, at the International Conference on Artificial Neural Networks and Genetic Algorithms (ICANNGA), a biannual meeting of the computa
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 1 April 1997
WEST LAFAYETTE, Ind.--(BW HealthWire)--April 1, 1997-- HemoCleanse Inc. announced that it has received approval and authorization from TUV Product Service, their European Notified Body, to put the CE Mark on the labeling of its BioLogic-DT Machine and disposable Treatment Kit. The CE Mark, recognized worldwide as an as
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday March 31 5:00 PM EDT
SAN FRANCISCO--(BUSINESS WIRE)--March 31, 1997-- Dignity Partners Inc today reported a net loss of $9.7 million (or ($2.46) per share based on 3,942,166 weighted average outstanding shares) for the year ended Dec. 31, 1996, compared to net income of $803,000 (or $.42 per share based on 1,902,482 outstanding shares) for
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 31 March 1997
BERKELEY, Calif.--(BW HealthWire)--March 31, 1997-- XOMA Corporation (NASDAQ:XOMA) is actively licensing its proprietary technology for the recombinant production of biopharmaceutical products. XOMA s bacterial cell expression system uses its patented genetic engineering technologies with proprietary fermentation proce
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 31 March 1997.
CAMBRIDGE, Mass.--(BW HealthWire)--March 31, 1997--Procept, Inc. (Nasdaq: PRCT) announced today that it has been issued Patent No. 5,614,559 for the use of PRO 2000 gel, a topical microbicide it is developing as a chemical barrier to prevent HIV infection and other STDs (sexually transmitted diseases). This patent cove
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 28 March 1997.
SAN FRANCISCO--(BW HealthWire)--March 28, 1997--Researchers at the UCSF Center for AIDS Prevention Studies (CAPS) have begun a new study to examine how gay men living with HIV are handling all of the new stresses of the changing epidemic. Due to major changes in available treatments, new challenges have emerged in the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 27 March 1997.
HOFFMAN ESTATES, Ill.--(BW HealthWire)--March 27, 1997-- Home Access Expands National OTC Availability For HIV-1 Home Test Option Home Access Health Corporation announced a retail distribution agreement with Wal-Mart Stores, Inc. (NYSE: WMT), the largest retailer in the world. The Home Access(TM) and Home Access Expres
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.
SAN DIEGO--(BW HealthWire)--March 26, 1997--Despite high standards for infection control within hospitals, millions of U.S. patients and health care workers each year contract life-threatening diseases, such as AIDS, hepatitis B and C and other infectious diseases. One of the reasons may be because health care workers
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.
SAN DIEGO--(BW HealthWire)--March 26, 1997-- Fluid Alarm System monitoring device reduces risks for passage of deadly viruses through latex gloves Medical Device Technologies Inc. (NASDAQ:MEDD,MEDDP,MEDDW) announced the results of three separate parallel studies commissioned by the company on the saturation of surgical
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 26 March 1997.
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--March 26, 1997-- Shaman Pharmaceuticals, Inc. (NASDAQ:SHMN) announced today that it has expanded its Phase II program for Provir, an oral product for the treatment of diarrhea, to conduct a pilot study that tests Provir for diarrhea in patients with AIDS. The double-blind,
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 March 1997.
EMERYVILLE, Calif.--(BW HealthWire)--March 25, 1997--Chiron Vision, a business of Chiron Corporation (NASDAQ:CHIR), announced today that the European Commission has granted a marketing authorization for the Vitrasert (TM) Implant in all 15 countries of the European Union. The market clearance follows a recommendati
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 24 March 1997.
OLYMPIA, Wash.--(BUSINESS WIRE)--May 24, 1997--Though the incidence of new tuberculosis cases has dropped 16 percent in Washington since 1991, the disease remains a concern. Many people may not know they are infected with the disease. Today is World TB Day, an opportunity to build awareness. Effective cures have been a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.
EMERYVILLE, Calif.--(BW HealthWire)--March 24, 1997--Chiron Corporation (Nasdaq:CHIR) today announced that, according to a study reported in the April issue of the Journal of Infectious Diseases by Richard Davey, M.D., Clifford Lane, M.D. and their colleagues at the National Institutes of Health (NIH), outpatient subcu
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.
MENLO PARK, Calif.--(BW HealthWire)--March 24, 1997--Geron Corporation (NASDAQ:GERN) and Pharmacia & Upjohn (NYSE:PNU) today announced that they have signed a definitive agreement to collaborate in the discovery, development and commercialization of a new class of anticancer drugs that inhibit telomerase, an enzym
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 March 1997.
PHOENIX--(BW HealthWire)--March 24, 1997--Zila Inc. (NASDAQ:ZILA), international provider of oral healthcare products for dental/medical professionals and consumers, announced that marketing of its oral cancer detection system, OraTest(TM), will begin in May in the Republic of China (
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 21 March 1997.
SAN FRANCISCO--(BW HealthWire)--March 21, 1997--The Brown & Toland Medical Group has recently compiled background information on the following topics: -0- Disease Management Programs -- HIV -- Asthma -- Geriatrics -- Congestive Heart Failure After-Hours Pediatric Care Wellness Programs Please let us know if we c
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 21 March 1997.
NASHVILLE, Tenn.--(BUSINESS WIRE)--March 21, 1997--Contrary to reports of recent outbreaks in Tennessee, tuberculosis or TB, still the leading infectious disease killer in the world, has declined in recent years. In fact, according to a new article published this week in Tennessee Medicine: The Journal of the Tennessee
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 20 March 1997.
FARMINGDALE, N.Y.--(BUSINESS WIRE)--March 20, 1997-- Potential wide application includes infectious disease management, gene therapy and organ transplantation Enzo Biochem Inc. (ASE:ENZ) announced today the filing of a U.S. patent application for a compound and novel procedure that could allow for the management of und
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 20 March 1997.
SAN DIEGO--(BW HealthWire)--March 20, 1997-- More than 77,000 patients die annually from infections at U.S. hospitals, statistics point to needed improvements in infection control monitoring Doctors say that if they were left with only one piece of protection in the operating room -- it would be their surgical latex gl
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 18 March 1997.
SAN FRANCISCO--(BW HealthWire)--March 18, 1997--As the one-year anniversary of federal approval for the new protease inhibitor drugs arrives, and as the California Department of Health Services is predicted to record the 100,000th AIDS case by the end of this month, San Francisco still faces an estimated 1,000 new HIV
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 18 March 1997.
FOSTER CITY, Calif.--(BW HealthWire)--March 18, 1997-- Gilead Sciences , Inc. (Nasdaq:GILD) announced today the premiere of its World Wide Web site (http://www.gilead.com). The site is designed to be a comprehensive resource for those who are interested in the company and its antiviral products in development. The
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 17 March 1997.
BERKELEY, Calif.--(BW HealthWire)--March 17, 1997--Calypte Biomedical Corp. (NASDAQ:CALY) announced today that it has completed the clinical trials requested by the U.S. FDA regarding the use of a urine-based Western blot for HIV-1 antibodies. The Western blot is intended to be used as a specific, supplemental test on
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN FRANCISCO--(BW HealthWire)--March 17, 1997--UC San Francisco AIDS specialists announced today (March 17) that anyone with access to a computer and to the world wide web can now obtain the most comprehensive, credible and trustworthy HIV/AIDS information available online with just a click of the mouse. The top-rated
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 14 March 1997.
SAN FRANCISCO--(BW HealthWire)--March 14, 1997--A shortage of type O blood in the Bay Area could present a serious situation for community blood centers. Two recent liver transplant patients at UCSF, for example, had the usual 20 units of type O blood set aside for their surgeries. However, most hospitals surgery units
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 12 March 1997.
WASHINGTON--(BUSINESS WIRE)--March 12, 1997--The GAO s conclusion that the blood supply is very safe will provide needed comfort to the millions of Americans each year who receive a blood transfusion in conjunction with a life-threatening health condition, said Byron Buhner, president of America s Blood Centers (ABC).
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 11 March 1997.
BERKELEY, Calif.--(BW HealthWire)--March 11, 1997--Newly- released results from clinical studies of XOMA Corporation s (NASDAQ:XOMA) Neuprex(TM) (rBPI21) product in hepatectomy and meningococcemia patients further demonstrate the product s safety and its potential to treat serious infections and infectious complication
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday March 7 11:17 AM EDT
ATLANTA--(BUSINESS WIRE)--March 7, 1997--Mark Barnes, a national expert on financing health care for people with HIV disease, will speak to the Georgia Task Force on AIDS at the Decatur Holiday Inn, 9:30 a.m. on March 21. He will discuss the impact changes in Medicaid and managed care will have on Georgians with HIV, a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 6 March 1997
(ADVANCE) SAN FRANCISCO--(BW HealthWire)--March 6, 1997--Veterans Affairs and UC San Francisco researchers have found evidence that certain HIV infected immune system cells cause AIDS-related dementia by programming brain cells to self destruct. Further, they say, rising numbers of these immune system cells may serve a
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 4 March 1997.
NASHVILLE, Tenn.--(BW HealthWire)--March 3, 1997--Health care reform is not a dead issue according to a new article published this week in Tennessee Medicine: The Journal of the Tennessee Medical Association. The Health Insurance Portability and Accountability Act (HIPA) that President Clinton signed in August 1996 wil
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 4 March 1997.
DUBLIN, Ohio--(BW HealthWire)--March 4, 1997--Neoprobe Corporation (NASDAQ NMS:NEOP) today will announce at the Raymond James Institutional Investor Conference that it has expanded its activated cellular therapy (ACT) program potentially to help boost HIV/AIDS patients own immune systems to fight the disease. The compa
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 4 March 1997.
MENLO PARK, Calif.--(BUSINESS WIRE)--March 4, 1997-- Product is Marketed in the United States Under the Trade Name DOXIL (R) SEQUUS Pharmaceuticals, Inc. (Nasdaq:SEQU) today announced that Schering-Plough Corp. has initiated sales of CAELYX(TM) (doxorubicin HCl [pegylated liposomal]) in the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 4 March 1997.
DUBLIN, Ohio--(BW HealthWire)--March 4, 1997--Neoprobe Corporation (NASDAQ NMS:NEOP) today will announce at the Raymond James Institutional Investor Conference that it has expanded its activated cellular therapy (ACT) program potentially to help boost HIV/AIDS patients own immune systems to fight the disease. The compa
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 3 March 1997.
SAN FRANCISCO--(BW HealthWire)--March 3, 1997--Needle exchange programs could have prevented nearly 10,000 HIV infections among injecting drug users, their sex partners and their children in the United States since 1987, according to a University of California San Francisco study published in the March 1 issue of the m
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 2 March 1997.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--March 2, 1997--More than 400 of the world s leading scientists, public health officials and water-utility professionals are gathering in Newport Beach Sunday to share information on a microscopic organism that can infect large and small cities alike. The organism that has drawn s
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
FORT LAUDERDALE, Fla.--(BW HealthWire)--March 20, 1997-- SEC appeal period ends March 20, opening door for agents to sell settlements to individual investors Insurance agents throughout the country are preparing for the passing of March 20, the appeal deadline for the Securities and Exchange Commission (SEC) in its fig
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 27 February 1997
SAN FRANCISCO--(BW HealthWire)--Feb. 27, 1997--The CDC is expected to release a Morbidity and Mortality Weekly Report today showing a 12% decline in AIDS deaths during the first six months of 1996 and an increase in the number of Americans living with AIDS. (The findings show a trend in the epidemic PRIOR to extensive
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 27 February 1997
(BW HealthWire)--28 Feb: Crypto-Scan data also will be presented to 400 of world s leading scientists as part of 4-day symposium on Cryptosporidium problem WHAT: ImmuCell Corp. (Portland, Maine) and its joint venture partner, Membrex Inc. (Fairfield, N.J.) will be demonstrating its breakthrough Crypto-Scan drinking wat
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 27 February 1997.
MENLO PARK, Calif.--(BUSINESS WIRE)--Feb. 27, 1997--SEQUUS Pharmaceuticals Inc. (Nasdaq:SEQU) today announced the receipt of market clearance for AMPHOTEC(TM) (amphotericin B cholesteryl sulfate complex for injection) in Portugal , bringing to 20 the number of countries, including the Unite
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 27 February 1997
WALTHAM, Mass.--(BW HealthWire)--Feb. 27, 1997--Hemagen Diagnostics Inc. (NASDAQ: HMGN) today announced it has received Food and Drug Administration 510(k) clearance to market its VIRGO ELISA CMV IgG kit. The test detects current or past cytomegalovirus (CMV) infection. The VIRGO ELISA CMV IgG test kit
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 27 February 1997.
BERKELEY, Calif.--(BW HealthWire)--February 27, 1997-- XOMA Corporation (Nasdaq: XOMA) announced positive results from a 400-patient Phase II clinical trial in patients suffering hemorrhagic trauma (acute loss of blood). Preliminary analysis of the data showed a positive overall benefit in patients receiving Neuprex (T
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 February 1997.
SAN FRANCISCO--(BW HealthWire)--Feb. 25, 1997--The UCSF Pediatric HIV Program is one of 21 clinical centers nationwide selected to receive major funding from the National Institute of Allergy and Infectious Disease. Directed by Diane W. Wara, MD, the UCSF Program focuses on both treatment and research in pediatric HIV,
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 25 February 1997
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Feb. 25, 1997--Shaman Pharmaceuticals, Inc. (Nasdaq: SHMN) announced today that it has begun patient enrollment in a double-blind, randomized, placebo-controlled, Phase II study of Virend, a topical agent for the treatment of recurrent genital herpes . The study will exa
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 24 February 1997.
STANFORD, Calif.--(BW HealthWire)--Feb. 24, 1997--Researchers at Stanford have found that HIV patients with ample levels of a small, hardworking molecule normally found throughout the body are likely to outlive patients whose stores are low. The more of these molecules patients carry in their CD4 T cells (the primary c
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 24 February 1997.
SAN FRANCISCO--(BUSINESS WIRE)--Feb. 24, 1997--A record number of people in 1996 attended displays of the AIDS Memorial Quilt held in more than 2,000 locations around the world. More than 4.5 million individuals visited Quilt displays in the United States and abroad -- including 1.2 million visitors who visited the Oct
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 22 February 1997.
SAN FRANCISCO--(BW HealthWire)--Feb. 21, 1997--There are many factors to consider when choosing a health plan: which doctors you can see, how much the plan costs, how long it has been in business, and what kinds of benefit packages are available. Much of this information is available from the health plans themselves.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 21 February 1997.
(BW HealthWire)--21 Feb: Researchers at Stanford have found that HIV patients with ample levels of a small, hard-working molecule normally found throughout the body are likely to outlive patients whose stores are low. Stanford genetics professor Leonard Herzenberg will present the new finding Saturday, Feb. 22, at the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 18 February 1997.
VANCOUVER, Wash.--(BUSINESS WIRE)--Feb. 18, 1997--Saliva Diagnostic Systems, Inc. (NASDAQ:SALV), has signed a letter of intent with BioChem ImmunoSystems, Inc., a division of BioChem Pharma Inc. (NASDAQ:BCHXF), for the distribution of SDS rapid HIV tests in parts of Europe, Latin America and Africa. BioChem ImmunoSyste
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 18 February 1997
FOSTER CITY, Calif.--(BW HealthWire)--Feb. 18, 1997-- Gilead Sciences , Inc. (Nasdaq: GILD) announced today the publication of data from two pivotal clinical studies that demonstrated the effectiveness of VISTIDE(R) (cidofovir injection) as a treatment for previously untreated, newly diagnosed
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 14 February 1997.
SAN FRANCISCO--(BW HealthWire)--Feb. 14, 1997--The San Francisco AIDS Foundation, which strongly endorses a just-released National Institutes of Health report that supports needle exchange, renews its call for local, state and federal government support of needle exchange programs. The San Francisco AIDS Foundation HIV
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
CANTON, Mass.--(BUSINESS WIRE)--Feb. 12, 1997--Avitar, Inc. ( the Company ) (Nasdaq SmallCap Market:AVIT (Common Stock); AVITW (Redeemable Warrants)) today announced that studies at a highly respected New England laboratory have verified the high protein recovery characteristics of the Avitar Accu-sorb(TM) Saliva Colle
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 13 February 1997.
EMERYVILLE, Calif.--(BW HealthWire)--Feb. 13, 1997--Chiron Corp. (NASDAQ:CHIR) announced today that it and partner Green Cross Corp. of Osaka, Japan , have agreed to expand human clinical studies of their jointly developed immunotherapeutic, HIV-IT(V). Green Cross will provide an additional $4 million for the year to c
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
(BW HealthWire)--Several hundred of the world s leading scientists will gather in Newport Beach, Calif., March 2-5 to discuss waterborne Cryptosporidium -- the microscopic parasite that caused at least 100 people to become ill and contributed to 40 deaths in Las Vegas in 1994. Media are invited to cover the three-day s
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 12 February 1997.
SCOTTSDALE, Ariz.--(BW HealthWire)--Feb. 12, 1997--Bio Fluorescent Technologies Inc. (BFTI) (OTC BB:BFTK) Wednesday announced that it has reached an agreement in principle to acquire all of the assets of Immune Network Research Ltd. ( INR ), of Vancouver, British Columbia, Canada , for approximately 9 million BFTI comm
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
SAN FRANCISCO--(BUSINESS WIRE)--Feb. 12, 1997--Under One Roof, the San Francisco-based non-profit store that raises funds for AIDS- related causes, and NetConsult Communications, a developer of Internet shopping software, today will unveil Under One Roof s virtual storefront on the World Wide Web, created with NetConsu
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 11 February 1997.
SAN FRANCISCO--(BW HealthWire)--Feb. 11, 1997--Patti Harris of San Ramon, CA, was recovering from breast cancer surgery when her surgeon, who was also monitoring her recovery, was terminated. If she wanted to continue seeing the surgeon, she was told, she would have to pay for the visits out of her own pocket. Elsewher
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 10 February 1997.
MILWAUKEE--(BUSINESS WIRE)--Feb. 10, 1997--400 of the world s leading scientists will gather in Newport Beach, Calif., March 2-5 to discuss Cryptosporidium, the microscopic parasite found in surface water that caused 100 deaths and 400,000 people to become ill in Milwaukee in 1993. The media are invited to cover the th
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 10 February 1997.
WEST LAFAYETTE, Ind.--(BW HealthWire)--Feb. 10, 1997-- HemoCleanse Inc., in conjunction with IDT Inc., announced that its BioLogic-HT System(TM) has been approved by the FDA for use in a feasibility study under an IDE for extracorporeal whole-body hyperthermia (WBH) treatment of metastatic non-small cell lung cancer.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Sunday, 9 February 1997.
ESTATES, Ill.--(BW HealthWire)--Feb. 9, 1997-- The Home Access(TM) test system provides people with a safe and accurate alternative to HIV testing in a doctor s office or clinic, according to a new study published in tomorrow s Archives of Internal Medicine. Among study findings are 100 percent agreement when investiga
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 7 February 1997
OLYMPIA, Wash.--(BUSINESS WIRE)--The annual meeting between the Governor s Advisory Council on HIV/AIDS and representatives from state AIDS service networks will be Feb. 11 at the Wyndham Garden Hotel, Salons A&B, 18118 Pacific Hwy South, in Seattle. The council s regular meeting will begin at 9 a.m. and the joint
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday February 6 2:21 PM EDT
SAN FRANCISCO--(BW HealthWire)--Feb. 6, 1997--As a result of recent medical advances, people with HIV are living longer, re-examining their life choices and beginning to form long term plans. Because of these changes, and in keeping with the Marcus A. Conant Foundation s mission of helping the HIV community lead health
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 6 February 1997.
SAN FRANCISCO--(BW HealthWire)--Feb. 6, 1997--On Monday, Feb. 10, the Marcus A. Conant Foundation will present a review of the 4th National Conference on Retroviruses & Opportunistic Infections. The conference, which took place in late January in Washington, D.C. is one of the most important gatherings in HIV/AIDS
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 February 1997.
THE WOODLANDS, Texas--(BW HealthWire)--Feb. 3, 1997-- GeneMedicine, Inc. (NASDAQ:GMED) announced today that it has received clearance from the U.S. Food and Drug Administration ( FDA ) to commence a Phase I clinical trial for its Interleukin-2 ( IL-2 ) Cancer Gene Medicine that is being developed for the treatmen
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 February 1997.
WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Feb. 4, 1997-- ALZA Corp. (NYSE: AZA) and U.S. Bioscience Inc. (AMEX:UBS) Tuesday announced that U.S. Bioscience will issue 1,178,882 common shares to ALZA (which will be 4.9% of the outstanding shares of U.S. Bioscience) at a purchase price of $18.256 per share for an aggregate
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 February 1997.
EAST HILLS, New York--(BW HealthWire)--February 4, 1997--Pall Corporation today announced that it has signed a Letter of Intent with LifeTECH Corporation of Toronto, Canada , to establish a strategic alliance. Pursuant to the Letter of Intent, Pall Corporation would receive the exclusive rights to manufacture, use, mar
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 3 February 1997.
NEW YORK--(BUSINESS WIRE)--February 3, 1997--Writing about your emotional conflicts can help your overall physical and mental health, according to a prominent Southern Methodist University psychologist. James W. Pennebaker, Ph.D., says in the current (February) issue of New Choices: Living Even Better After 50, Researc
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Wednesday, 29 January 1997.
BERKELEY, Calif.--(BW HealthWire)--Jan. 29, 1997--Calypte Biomedical Corporation (Nasdaq:CALY) announced today that it has entered into a collaborative research and product development agreement with Trinity Biotech plc of Dublin, Ireland (Nasdaq:TRIBY) to develop a rapid, one-step HIV test which can be performed o
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 24 January 1997.
WASHINGTON--(HealthWire)--Jan. 24, 1997-- -- DOXIL (R) vs. ABV, BV Efficacy and Safety Data To Be Presented at Conference on Retroviruses and Opportunistic Infections -- DOXIL(R) is indicated for first-line treatment for Kaposi s sarcoma (KS) and is suitable for long-term therapy, based on integrated efficacy and safet
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 23 January 1997
WASHINGTON--(BUSINESS WIRE)--Jan. 23, 1997--Physicians who are experienced in treating patients with HIV disease are more likely to begin treatment with antiretroviral therapy early in the disease and also are more likely to treat opportunistic infections appropriately, researchers at the Community Consortium have repo
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 23 January 1997.
WASHINGTON--(BW HealthWire)--Jan. 23, 1997--Research scientists from Gilead Sciences , Inc. (Nasdaq: GILD) and clinical investigators working with the company will present eight abstracts summarizing new data on several Gilead antiviral compounds at the Fourth Conference on Retroviruses and Opportunistic Infections (he
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 22 January 1997.
VANCOUVER, BRITISH COLUMBIA--(BUSINESS WIRE)--Jan. 22, 1997-- ID Biomedical Corpor (TSE IDB., NASDAQ IDBEF.) ID Biomedical Corporation (IDB) announced today that it is developing a rapid culture confirmation test for tuberculosis (TB) in collaboration with Dr. Kathy Eisenach of the University of Arkansas. The TB test w
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 21 January 1997.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 21, 1997-- Procept, Inc. (Nasdaq: PRCT) announced today that it has initiated a Phase I clinical trial of its PRO 2000 topical microbicide in London, England. The intravaginally applied gel is intended to protect women from infection by HIV and other sexually transmitted diseases
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday January 20 10:30 AM EDT
TORONTO--(BUSINESS WIRE)--Jan. 20, 1997--Allelix Biopharmaceu (TSE/ME:AXB) Allelix Biopharmaceuticals Inc. (TSE/ME:AXB) today announced that it has decided not to pursue further development of ALX40-4C, its peptide molecule for treatment of HIV and CMV infection. A recently completed analysis of the data from the P
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 20 January 1997, 12:47 Pacific
CARLSBAD, Calif.--(BUSINESS WIRE)--Jan. 20, 1997--A new poll conducted by NTN Communications Inc. (ASE:NTN) revealed that 78 percent of adults surveyed believe physician- assisted suicide for the terminally ill should be legalized by the federal government. NTN, a leading interactive producer and programmer, broadcast
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 20 January 1997.
FOSTER CITY, Calif.--(HealthWire)--Jan. 20, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today that the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA), sponsored by the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health (NIH), has begun enrolli
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 17 January 1997.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 17, 1997--Delphi Internet Services Corporation today announced that it has started a new Delphi Community on AIDS, hosted by Dr. William M. Valenti, an internationally-recognized AIDS doctor, researcher and patient advocate. Dr. Valenti will be leading an on-line discussion of AI
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 14 January 1997.
SUNNYVALE, Calif.--(BUSINESS WIRE)--Jan. 14, 1997--ChemTrak Inc. on Tuesday announced the signing of a distribution agreement with Selfcare Inc. of Waltham, Mass., to introduce HIV home testing and counseling services throughout Europe. The agreement calls for licensing of ChemTrak s home HIV testing systems including
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 13 January 1997
PHILADELPHIA--(HealthWire)--January 13, 1997--HEMISPHERx BIOPHARMA INC. (NASDAQ: HEMX, HEMXW) announced today that they had begun a new Phase II clinical trial in Texas treating HIV infected patients with the Company s proprietary drug, Ampligen(R). The trial, recently approved by the FDA , will study the effect of
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday January 13 1:07 PM EDT
PHILADELPHIA--(HealthWire)--January 13, 1996--HEMISPHERx BIOPHARMA INC. (NASDAQ: HEMX, HEMXW) announced today that they had begun a new Phase II clinical trial in Texas treating HIV infected patients with the Company s proprietary drug, Ampligen(R). The trial, recently approved by the FDA , will study the effect of
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 10 January 1997.
LOS ANGELES--(BUSINESS WIRE)--Jan. 10, 1997--Dr. Joseph Mo, president & C.E.O. of NexMed, Inc. (OTC BULLETIN BOARD:NEXM) announced today that the company has initiated two clinical studies in China . The Beijing office of Innapharma, a CRO based in Upper Saddle River, N.J., will manage the clinical sites and carry
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday January 9 2:59 PM EDT
DUARTE, Calif.--(HealthWire)--Jan. 9, 1997--Researchers this month will begin testing gene therapy using marrow transplantation in humans to fight AIDS. Researchers at City of Hope National Medical Center and Beckman Research Institute, a pioneer in bone-marrow-transplantation treatment for cancer, will begin treating
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - 7 January, 1997.
LAVAL, Quebec--(BUSINESS WIRE)--Jan. 7, 1997--Biochem Pharma (ME, TSE: BCH., NASDAQ: BCHXF) Building on the success of our flagship drug discovery, 3TC (R) ( Epivir (TM)), a leading HIV/AIDS treatment, BioChem Pharma is focused on advancing more compounds toward clinical testing in the preventio
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 7 January 1997.
(ADVANCE) SAN FRANCISCO--(BUSINESS WIRE)--Jan. 7, 1997--UC San Francisco AIDS researchers have published a review and commentary on the use of protease inhibitors for HIV-infected patients. The review is intended to assist clinicians and their patients in the rational use of this potent class of drugs. The researc
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 7 January 1997.
BOULDER, Colo.--(BUSINESS WIRE)--Jan. 7, 1997--NeXstar Pharmaceuticals, Inc., (NASDAQ:NXTR) announced today that the Swiss Ministry of Health has approved separately AmBisome and DaunoXome. The Company will launch both drugs in Switzerland shortly. The Swiss Ministry approved AmBisome, the Company s liposomal antifunga
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 6 January 1997.
FOSTER CITY, Calif.--(Health Wire)--Jan. 6, 1997-- Gilead Sciences , Inc. (NASDAQ:GILD) announced today the filing of a New Drug Application (NDA) to market FORVADE(TM) (cidofovir gel) to treat refractory herpes simplex virus (HSV) infection in patients with AIDS. The U.S. Food and Drug Administration (
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 6 January 1997.
NEW YORK--(HealthWire)--Jan. 6, 1997--Optimistic and welcome press accounts to the contrary, the search to significantly prolong life for AIDS patients, and the quest to manage or control the HIV virus, continue. The sensational headlines about the progress and promise of new drug combinations with
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 6 January 1997.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 6, 1997--Celtrix Pharmaceuticals, Inc. (NASDAQ:CTRX) today reported that it has initiated Phase II clinical feasibility studies of SomatoKine(R), its novel IGF-BP3 complex. Initial treatment targets are elderly patients with reduced bone and muscle mass who have undergone hip
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 6 January 1997.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Jan. 6, 1997--Celtrix Pharmaceuticals, Inc. (NASDAQ:CTRX) today reported that it has successfully completed Phase I human clinical studies of SomatoKine(R), its novel IGF-BP3 complex. Safety, pharmacokinetic and metabolic data have led to three important conclusions: 1) repeated or
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Monday, 6 January 1997.
BOUNTIFUL, Utah--(BUSINESS WIRE)--Jan. 6, 1997--Specialized Health Products International, Inc. (NASDAQ: SHPI) announced today that its wholly-owned subsidiary, Specialized Health Products, Inc. (SHP) has been allowed a sixth patent relating to the Company s proprietary Safety Cradle sharps containers by the
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Tuesday, 4 February 1997.
SAN DIEGO--(BW HealthWire)--Feb. 3, 1997--Gen-Probe Inc. today announced that its extremely sensitive, noninvasive test for Chlamydia trachomatis (CT), the Gen-Probe Amplified CT Assay, has been cleared by the Food and Drug Administration for sale in the United States . Chlamydia -- the most prevalent sexually transmit
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 3 January 1997.
LOS ANGELES--(BUSINESS WIRE)--Jan. 3, 1997--The Housing Authority of the City of Los Angeles (HACLA) is kicking off the new year by filling the gap by providing housing referrals for people with AIDS and HIV. When a nonprofit housing referral service went bankrupt late last year, some of the services provided by Los An
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Friday, 3 January 1997.
HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Jan. 3, 1997--The U.S. Food and Drug Administration ( FDA ) has approved the licensure of a test for the AIDS virus types 1 and 2 (HIV-1,2). The test, manufactured by United Biomedical Inc. (UBI(R)), Hauppauge, N.Y., is based on synthetic peptides and detects antibodies to the viruses.
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 - Thursday, 2 January 1997.
SAN ANTONIO and MATTAWAN, Mich.--(BUSINESS WIRE)--Jan. 2, 1997--ILEX(TM) Oncology Inc. and MPI Development today announced they have formed a limited partnership for the development of piritrexim. Piritrexim, a DNA synthesis inhibitor, is being developed for the treatment of bladder cancer, early stage Kaposi s sarcoma
BUSINESS WIRE - 44 Montgomery St, 39th Floor, San Francisco, CA 94104; Tel: (415) 986-4422; FAX: (415) 788-5335 -
WACO, TEXAS--(HealthWire)--Jan. 2, 1997--Petition to rehear Life Partners decision denied; earlier ruling favorable to ill, taxpayers, investors upheld The United States Court of Appeals for the District of Columbia Circuit in late December 1996 denied the U.S. Securities and Exchange Commission s petition to rehear th
This information is designed to support, not replace, the relationship that exists between you and your doctor.